DWA
LFMD icon

Dorsey Wright & Associates’s LifeMD LFMD Stock Holding History

Dorsey Wright & Associates’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,897
Closed -$36.9K – 216
2023
Q3 		$36.9K Buy
+5,897
New +$25.6K 0.01% 155

Other funds holding LFMD

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dorsey Wright & Associates's LFMD Position: Q4 2023 in Review

Dorsey Wright & Associates sold out of LifeMD (LFMD) in Q4 2023, closing a stake of 5,897 shares — an estimated $36.9K sold.

Dorsey Wright & Associates first reported a position in LFMD in Q3 2023 and held it in 1 quarter. The position peaked at $36.9K in Q3 2023. 84 funds tracked by Wall St. Rank hold LFMD as of Q4 2023.

  • Dorsey Wright & Associates reported no remaining LifeMD position as of Q4 2023 after selling out during the quarter.
  • Dorsey Wright & Associates sold 5,897 LifeMD shares in Q4 2023, an estimated $36.9K.
  • Dorsey Wright & Associates first reported a position in LifeMD in Q3 2023 and held it in 1 quarter.
  • Dorsey Wright & Associates's LifeMD position peaked at $36.9K in Q3 2023.
  • 84 funds tracked by Wall St. Rank held LifeMD as of Q4 2023.

Based on Dorsey Wright & Associates's 13F filing for Q4 2023, filed 13 Feb 2024.